Passage Bio Inc
PASG
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.14M
Close$
$7.03
53.6% upside
Current Fair Value
53.6% upsideUndervalued by 53.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.14 Million |
|---|---|
| Enterprise Value | $6.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.35 |
| Beta | 1.42 |
| Outstanding Shares | 3,205,866 |
Return
| Return on Equity | -810.41% |
|---|---|
| Return on Assets | -143.44% |
| Return on Invested Capital | -875.58% |
Valuation & Multiples
| P/E Ratio | -0.37 |
|---|---|
| PEG | 2.23 |
| Price to Sales | - |
| Price to Book Ratio | 4.58 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.61 |
| Debt to Equity | 3.65 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-2.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-2.16
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 55.52%▲ 5.81% |
|---|---|
| Total Invested | $13.83M▼ 25.69% |
| Investors Holding | 33▲ 4.00% |
ESG Score
No data